Fever Evaluation in Pregnant Patients: A Comprehensive Clinical Review

Abstract

Fever in pregnancy is a critical clinical scenario requiring prompt evaluation and careful management due to potential maternal and fetal risks. This review synthesizes current evidence, guideline recommendations, and expert clinical insights regarding the epidemiology, pathophysiology, risk factors, clinical presentation, diagnostic approach, and management strategies of fever in pregnant patients. Emphasis is placed on mechanism-based explanations, recent advances, and practical implications for healthcare professionals involved in obstetric care.

Introduction

Fever, defined as an elevation of body temperature above the normal physiologic range, is a common presenting symptom among pregnant women and carries unique diagnostic and therapeutic challenges. The altered physiological state of pregnancy modifies immune responses and pharmacokinetics, complicating both the evaluation and management of febrile illnesses. Prompt identification of the underlying etiology is paramount, as fever during pregnancy is associated with increased risk of adverse outcomes including miscarriage, preterm labor, and fetal anomalies. This article provides a comprehensive review of the clinical approach to fever in pregnancy, integrating recent guideline-based recommendations and evidence from PubMed-indexed literature.

Epidemiology / Disease Burden

The incidence of fever in pregnant women ranges from 2% to 10%, varying by geographic region, socioeconomic status, and underlying infectious disease prevalence. Common etiologies include urinary tract infections, respiratory tract infections, and intra-amniotic infections. In developing countries, infections such as malaria, dengue, and typhoid fever also contribute significantly to the disease burden. Fever is a leading cause of hospital admission during pregnancy, and infectious morbidity remains a major contributor to maternal and perinatal mortality worldwide. Understanding the epidemiological context is essential for risk stratification and targeted diagnostic evaluation.

Pathophysiology

During pregnancy, immune modulation occurs to prevent fetal rejection, leading to relative immunosuppression. This adaptive response increases susceptibility to certain pathogens and can alter the clinical course of infections. Pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α mediate the febrile response via hypothalamic thermoregulatory centers. Infections may also trigger systemic inflammatory response syndrome (SIRS), which can precipitate preterm uterine contractions, compromise placental perfusion, and contribute to fetal distress. Non-infectious causes of fever, though less common, include autoimmune diseases, drug reactions, and neoplastic processes, warranting thorough differential diagnosis.

Risk Factors

Several maternal and environmental factors predispose pregnant women to febrile illnesses. These include advanced maternal age, pre-existing comorbidities (e.g., diabetes, chronic kidney disease), immunosuppression, poor socioeconomic conditions, and limited access to prenatal care. Hospitalized or institutionalized patients and those with indwelling devices are at increased risk for nosocomial infections. Travel to endemic regions further increases the risk of exposure to vector-borne and zoonotic pathogens. Recognizing these risk factors facilitates early identification and preventive strategies in at-risk populations.

Clinical Features

The clinical presentation of fever in pregnancy is heterogeneous and often overlaps with physiological changes of gestation. Common symptoms include malaise, chills, myalgia, and localized signs depending on the underlying source dysuria and flank pain in urinary tract infection, cough and dyspnea in pneumonia, or lower abdominal pain and vaginal discharge in intra-amniotic infection. High-grade fevers, rigors, and toxic appearance may indicate severe or systemic infection. Fetal tachycardia and reduced fetal movements are concerning signs of fetal compromise and warrant urgent evaluation. A thorough history and systematic examination are crucial for guiding the diagnostic workup.

Diagnosis

Evaluation of fever in pregnancy necessitates a methodical approach, balancing the need for diagnostic accuracy with fetal safety. Initial assessment includes a detailed clinical history, physical examination, and targeted laboratory investigations. Urinalysis and urine culture are essential for ruling out urinary tract infection, the most common cause of fever in pregnancy. Blood cultures, complete blood count, inflammatory markers (CRP, procalcitonin), and serologic tests are indicated based on clinical suspicion. Imaging modalities such as ultrasound and chest radiography (with abdominal shielding) are safe in pregnancy and aid in localizing infection. Advanced diagnostics, including PCR-based assays and specific serologies, are increasingly utilized for rapid pathogen identification. Lumbar puncture may be necessary in cases of suspected meningitis or encephalitis, with careful consideration of maternal and fetal risks.

Treatment & Management

The management of fever in pregnancy is tailored to the underlying etiology, gestational age, and severity of maternal illness. Empirical antibiotic therapy is initiated promptly in cases of suspected bacterial infection, with selection guided by local resistance patterns and safety profiles in pregnancy beta-lactams, cephalosporins, and certain macrolides are preferred. Antiviral or antifungal agents may be indicated based on clinical context. Antipyretics such as acetaminophen are considered safe and effective for temperature control, while non-steroidal anti-inflammatory drugs are generally avoided, especially in the third trimester. Supportive measures include adequate hydration, monitoring of vital signs, and fetal surveillance. Hospitalization is warranted for severe infections, high-risk pregnancies, or when intravenous therapy and close monitoring are necessary. Multidisciplinary collaboration with obstetricians, infectious disease specialists, and neonatologists optimizes maternal and fetal outcomes.

Recent Advances / Emerging Therapies

Recent developments in diagnostic and therapeutic approaches have enhanced the management of fever in pregnancy. Rapid molecular diagnostic platforms, including multiplex PCR panels, enable early pathogen identification and targeted therapy. Biomarkers such as procalcitonin are being evaluated for their utility in distinguishing bacterial from viral infections, potentially reducing unnecessary antibiotic use. Novel antimicrobial agents with improved safety profiles in pregnancy are under investigation. Immunization strategies, including influenza and COVID-19 vaccines, have demonstrated efficacy in reducing infectious morbidity among pregnant women. Ongoing research into host-pathogen interactions and maternal-fetal immunology holds promise for future therapeutic innovations.

Guideline Recommendations

Major guidelines from the American College of Obstetricians and Gynecologists (ACOG), Centers for Disease Control and Prevention (CDC), and the World Health Organization (WHO) emphasize prompt evaluation and empiric management of fever in pregnancy. Key recommendations include routine screening for asymptomatic bacteriuria, early initiation of appropriate antibiotics in suspected infection, and avoidance of potentially teratogenic medications. Maternal vaccination against influenza and pertussis is advocated to reduce infection risk. Fetal monitoring is advised in all cases of maternal pyrexia, with expedited delivery considered in the setting of chorioamnionitis or fetal compromise. Guideline-driven care is associated with improved maternal and neonatal outcomes.

Conclusion

Fever in pregnant patients represents a clinically significant challenge with potential for serious maternal and fetal complications. A thorough understanding of the epidemiology, pathophysiology, risk factors, and evidence-based management strategies is essential for optimizing care. Advances in diagnostics and therapeutics, coupled with adherence to established guidelines, have improved outcomes for this vulnerable population. Continued research and education are necessary to address emerging infectious threats and refine management approaches in the evolving landscape of obstetric care.